Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...

Genelux Corp. (($GNLX)) announced an update on their ongoing clinical study. Genelux Corp. is currently conducting a Phase 2 clinical study titled ...

Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...

BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Please provide your email address to receive an email when new articles are posted on . People with cancer who received statins during immune checkpoint inhibitor therapy had improved prognosis.

The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...

Please provide your email address to receive an email when new articles are posted on . Patients who received PD-1 or PD-L1 agents exhibited increased risk for psoriasis. Medical professionals should ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of immune checkpoint inhibitors for cancer was associated ...